Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $497.10 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $158.10 | 2 | $0 (2024) |
| Horizon Therapeutics plc | $86.70 | 1 | $0 (2023) |
| Novo Nordisk Inc | $39.74 | 2 | $0 (2024) |
| BETA BIONICS, INC. | $31.69 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.14 | 1 | $0 (2024) |
| Abbott Laboratories | $24.63 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $21.06 | 1 | $0 (2024) |
| Kyowa Kirin, Inc. | $20.83 | 1 | $0 (2024) |
| Corcept Therapeutics | $19.95 | 1 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $19.78 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $397.82 | 13 | Amgen Inc. ($158.10) |
| 2023 | $86.70 | 1 | Horizon Therapeutics plc ($86.70) |
| 2021 | $12.58 | 1 | Medtronic, Inc. ($12.58) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: ENDOCRINE AGENT | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $31.69 | General |
| Category: Automated insulin delivery system | ||||||
| 10/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Diabetes Care | ||||||
| 09/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Endocrinology | ||||||
| 09/05/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 05/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $79.05 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $79.05 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/30/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $86.70 | General |
| Category: TEPEZZA | ||||||
| 03/05/2021 | Medtronic, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Spinal Cord Neurostimulation | ||||||
About Dr. Lucy Esteve, MD
Dr. Lucy Esteve, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2017. The National Provider Identifier (NPI) number assigned to this provider is 1407388317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lucy Esteve, MD has received a total of $497.10 in payments from pharmaceutical and medical device companies, with $397.82 received in 2024. These payments were reported across 15 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($497.10).
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Austin, TX
- Active Since 03/30/2017
- Last Updated 06/10/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1407388317
Products in Payments
- TEPEZZA (Biological) $158.10
- TEPEZZA (Drug) $86.70
- iLet Bionic Pancreas (Device) $31.69
- JARDIANCE (Drug) $28.14
- FREESTYLE LIBRE 3 (Device) $24.63
- Kerendia (Drug) $21.06
- Crysvita (Drug) $20.83
- Rybelsus (Drug) $20.53
- Korlym (Drug) $19.95
- RECORLEV (Drug) $19.78
- Ozempic (Drug) $19.21
- TZIELD (Biological) $18.72
- ISTURISA (Drug) $15.18
- INTELLIS (Device) $12.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Austin
Dr. Thomas Blevins, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.5M
Michele Mcdermott, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $137,974
Tira Chaicha-Brom, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $56,872
Dr. Simona Scumpia, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $52,573
Dr. Padma Horvit, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $20,822
Farheen Yousuf, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $9,161